NCT00667069 2025-06-05
Triptorelin and Radiation Therapy in Treating Patients Who Have Undergone Surgery for Intermediate-Risk Stage III or Stage IV Prostate Cancer
UNICANCER
Phase 3 Completed
UNICANCER
University College, London
Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan
UNICANCER
Mayo Clinic
OHSU Knight Cancer Institute